Abstract Although pulmonary hypertension (PH) selectively overloads the right ventricle (RV), neuroendocrine activation and intrinsic myocardial dysfunction have been described in the left ventricle (LV). In order to establish the timing of LV dysfunction development in PH and to clarify underlying molecular changes, Wistar rats were studied 4 and 6 weeks after subcutaneous injection of monocrotaline (MCT) 60 mg/kg (MCT-4, n = 11; MCT-6, n = 11) or vehicle (Ctrl-4, n = 11; Ctrl-6, n = 11). Acute single beat stepwise increases of systolic pressure were performed from baseline to isovolumetric (LVPiso). This hemodynamic stress was used to detect early changes in LV performance. Neurohumoral activation was evaluated by measuring angiotensin-converting enzyme (ACE) and endothelin-1 (ET-1) LV mRNA levels. Cardiomyocyte apoptosis was evaluated by TUNEL assay. Extracellular matrix composition was evaluated by tenascin-C mRNA levels and interstitial collagen content. Myosin heavy chain (MHC) composition of the LV was studied by protein quantification. MCT treatment increased RV pressures and RV/LV weight ratio, without changing LV end-diastolic pressures or dimensions. Baseline LV dysfunction were present only in MCT-6 rats. Afterload elevations prolonged s and upward-shifted end-diastolic pressure dimension relations in MCT-4 and even more in MCT-6. MHC-isoform switch, ACE upregulation and cardiomyocyte apoptosis were present in both MCT groups. Rats with severe PH develop LV dysfunction associated with ET-1 and tenascin-C overexpression. Diastolic dysfunction, however, could be elicited at earlier stages in response to hemodynamic stress, when only LV molecular changes, such as MHC isoform switch, ACE upregulation, and myocardial apoptosis were present.
Introduction
Although chronic pulmonary hypertension (PH) selectively overloads the right ventricle (RV), left ventricular (LV) dysfunction also manifests in the course of primary PH [32] , chronic thromboembolism [13] and cor pulmonale [41] . Echocardiography-based studies carried out in PH patients suggested that one of the mechanisms contributing to LV dysfunction is ventricular interdependence and impaired LV filling [35] . Other studies, however, provide evidences that intrinsic LV myocardial abnormalities also contribute to LV dysfunction in severe PH [11, 12, 24, 33] .
In fact, the LV of rats with severe longstanding PH induced by monocrotaline (MCT) presents local autocrine/paracrine system activation and muscle strips dissected from the LV myocardium show, in vitro, negative force-frequency relationships (FFR) [33] . Intrinsic LV myocardial abnormalities might help to explain late recovery of LV filling after single-lung transplantation in patients with PH, even if LV geometry and RV function are immediately restored [50] . They might explain as well, why combined heartlung transplantation is favored for PH patients when severe impairment of LV function is present, since LV function may not sufficiently recover after transplantation of the lungs alone [39] .
The timing of development and the underlying mechanisms of intrinsic LV myocardial dysfunction were incompletely investigated so far. In the present study, we analyzed biventricular hemodynamics, LV myosin heavy chain (MHC) protein isoforms, LV myocardial expression of genes involved in neurohumoral activation (angiotensin-converting enzyme and endothelin-1), extracellular matrix remodelling (tenascin-C gene expression and interstitial fibrosis) and apoptosis (TUNEL assay), 4 and 6 weeks after MCT injection. Hemodynamics were studied at baseline and in response to single-beat afterload elevations, which allow the detection of diastolic dysfunction that may not be evident during evaluation at rest, but is revealed during exercise or hemodynamic stress [9, 10, 19, 20, 26, 48] .
Methods

Animal protocol
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and the experiments were performed according to the Portuguese law on animal welfare. Seven-weeks-old male Wistar rats (n = 58; Charles-River, Barcelona, Spain) were housed in groups of three per cage in a controlled environment under a 12:12 h light/dark cycle at a room temperature of 22°C. Rats randomly received, a subcutaneous injection of monocrotaline (MCT, 60 mg/kg; Sigma Chemical, St. Louis, MO, USA; n = 36) or an equal volume of vehicle (Ctrl, n = 22; 1 mL/kg). Animals had free supply of food and water. Hemodynamic studies and collection of samples for molecular and histological studies were carried out, for control and MCT-treated rats, at days 22, 24 or 26 (fourth week), Ctrl-4 (n = 11) and MCT-4 (n = 11), respectively, and at days 36, 38 or 40 (sixth week) after injection, Ctrl-6 (n = 11) and MCT-6 (n = 11), respectively.
Hemodynamic studies
Experimental preparation
Animals were anesthetized with an intraperitoneal injection of 60 mg/kg pentobarbital sodium and additional boluses of 20 mg/kg when needed, placed over a heating pad, and mechanically ventilated (Harvard Rodent Ventilator model 683) through a tracheostomy. The right jugular vein was cannulated and a pre-warmed 0.9% NaCl solution was administrated to compensate for perioperative fluid losses. The heart was exposed through a median sternotomy and the pericardium widely opened. The ascending aorta was dissected and surrounded by a silk thread in order to transiently occlude it during the experimental protocol. RV pressure was measured with a 2F high-fidelity micromanometer (SPR-324, Millar Instruments, Houston, TX, USA) inserted through the RV free wall into the RV cavity and LV pressure with a 3F high-fidelity micromanometer (SPR-407, Millar Instruments, Houston, TX, USA) inserted through an apical puncture into the LV cavity. LV septal to free wall diameter was recorded with ultrasonic crystals using a sonomicrometer amplifier (Triton Technology, San Diego, CA, USA). One crystal was placed into the left border of the interventricular septum and the other on the epicardial surface of the LV free wall, as previously described [3, 4] . A limb ECG (II) was recorded throughout. After the instrumentation period (typically 60 min), the animal was allowed to stabilize for 15 min before the beginning of the experimental protocol. Recordings were made with ventilation suspended at end-expiration. Parameters were converted on line to digital data with a sampling frequency of 1,000 Hz.
Data analysis
Peak rates of LV and RV pressure rise (dP/dt max ) and fall (dP/ dt min ) were determined. RV and LV pressures were measured at end-diastole (EDRVP and EDLVP, respectively) and at peak-systole (RVP max and LVP max ). Relaxation rate was estimated with the time constant s, by fitting isovolumetric LV pressure fall to a monoexponential function. From baseline to isovolumetric, multiple graded LV pressure elevations were randomly performed by abruptly clamping the ascending aortic root starting in the diastole separating two heartbeats, as previously described [3, 4, 25, 31] . Beats preceding aortic obstruction were designated as baseline heartbeats and those immediately following it as test beats. Along with the baseline hemodynamics, four afterloaded testbeats with a peak systolic pressure of approximately 60, 70, 80, and 90 of the isovolumetric pressures, and the isovolumetric test-beat were selected for analysis. LV septum to free wall diameter was measured at end-diastole. Afterload-induced shifts of the end-diastolic pressure-dimension relation (EDPDR) were assessed by measuring diastolic pressures at matched dimensions, close to end-diastole, as previously described [3, 4, 29, 30] .
At the end of the hemodynamic study animals were euthanized with anesthetic overdose, the position of crystals and manometers was verified, the RV was carefully dissected from the interventricular septum and LV free wall, and transmural samples of LV free wall (excluding the septum) were collected for molecular studies. Two MCT-6 rats died during hemodynamic instrumentation, having been excluded from analysis.
Morphometric determination of cardiac fibrosis
Transverse-sections of paraffin-embedded, formalin-fixed specimens encompassing the LV free-wall were stained with Masson's Trichrome and photographed with a digital camera (Leica DFC320) in additional animals (n = 5 per group). A 330-point grid was superimposed on ten fields (4009) randomly selected on each section. Two independent blinded observers rated the images and the area-percent of blue staining, indicative of fibrosis, was calculated as follows: (total number of blue-positive points/total number of points) 9 100.
Detection of apoptotic cardiomyocytes
To assess the extent of apoptosis the terminal deoxynucleotidyl-transferase-mediated dUTP nick end-labeling (TUNEL) assay was used (CardioTACS TM in situ Apoptosis Detection Kit, R&D Systems, Minneapolis, MN, USA). Briefly, after deparaffinization tissue slides were immersed in phosphate-buffered saline (PBS) pH 7.4 and then permeabilized with proteinase K for 20 min at room temperature. Endogenous peroxidase activity was quenched using 5.0% hydrogen peroxide. Then, specimens were incubated in TdT labeling buffer for 5 min. After that, slides were incubated with a mix containing the terminal deoxynucleotidyl transferase (TdT), Mn 2? and biotinylated nucleotides for 1 h at 37°C, blocked with stop buffer, and incubated with streptavidin-HRP for 10 min at room temperature. After washing in PBS, the slides were finally developed using TACS Blue Label. Nuclear staining by Nucler Fast Red was performed as counterstaining. Positive control of the TUNEL assay was generated by staining by the treatment of the samples with TACS-Nuclease TM prior to the labeling protocol. Negative control of the TUNEL assay was confirmed by staining of the heart tissue in the same manner without TdT. We used three sections obtained at a distance of 100 lm from each tissue block. TUNEL-positive cardiomyocytes were counted in at least 50 optical fields (4009) of each specimen. The apoptotic rate was expressed as a percentage of apoptotic cells of all cardiomyocytes per field.
Molecular studies
Relative quantification of mRNA Two-step Real-time RT-PCR was performed as previously described [14, 15, 33, 40] . Briefly, after total mRNA extraction (no. 74124, QIAGEN), standard curves were obtained using graded dilutions of a rat cardiac tissue sample. The starting mRNA quantities were correlated (R C 0.98) with the respective threshold cycles, for each gene. Threshold cycles were automatically calculated by software (LightCycler, ROCHE) using the second derivative maximum method. An equal amount of mRNA from every sample underwent two separate two-step real time RT-PCR experiments for each gene, using SYBR green as marker (no. 204143, QIAGEN). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as internal control since its mRNA levels were similar in the studied groups. Results are normalized for GAPDH and presented in arbitrary units. The arbitrary unit was set as the mean obtained for the Ctrl-4 group. Specific PCR primer pairs for the studied genes were: endothelin-1 (ET-1), fw 
Relative quantification of myosin heavy-chain isoforms
Total protein (15 lg) was separated by SDS-PAGE (3.0% stacking and 5.0% running polyacrylamide gels). Electrophoresis was carried out at constant voltage (60 V) for *270 min (no. 165-3301, BIO-RAD), allowing the separation of myosin heavy-chain isoforms a and b isoforms in two distinct bands visible at *200 KDa. Gels were silverstained following the manufacturer's instructions (no. 161-0449, BIO-RAD) and the relative amount of the myosin heavy-chain isoforms in each sample was quantified by densitometry (Multilmage Light Cabinet; ALPHA INNO-TECH CORPORATION).
Statistical analysis
Values were expressed as mean ± SEM. Differences in baseline hemodynamic parameters, morphology, and molecular studies were evaluated by two-way ANOVA.
Three-way ANOVA was employed to compare data from graded afterload elevations. Holm-Sidak's method was used for multiple comparisons when significant differences were detected. Statistical significance was assumed at a two-tailed value of P \ 0.05.
Results
All MCT-6 animals presented clinical signs of congestive heart failure such as lethargic behavior, ruffled fur, cachexia, tachypnea and severe breathing effort, pleural effusion, and ascites. MCT-4 animals behaved similarly to control animals. Mortality was null in Ctrl-4 and Ctrl-6, 33% in MCT-4 and 70% in MCT-6. No significant differences were observed between Ctrl-4 and Ctrl-6 for morphometric, hemodynamic and molecular parameters.
Baseline hemodynamics and morphometry MCT treatment resulted in progressively increasing RV peak-systolic pressures (Fig. 1a) . Increased RV pressures were accompanied by selective RV hypertrophy, as denoted by the progressive increase of the RV to LV plus interventricular septum weight ratio (Fig. 1b) . RV end-diastolic pressures were significantly increased in MCT-6 (4.9 ± 1.0 vs. 1.9 ± 0.5, 0.5 ± 0.3, and 1.1 ± 0.6 mmHg, in MCT-4, Ctrl-4, and Ctrl-6, respectively). Compared with the other groups, MCT-6 also presented lower body weight and heart rate (216 ± 9 vs. 287 ± 7, 265 ± 20, and 270 ± 20 beats/min, in MCT-4, Ctrl-4, and Ctrl-6, respectively). Both systolic (Fig. 2 ) and diastolic parameters (Fig. 3 ) were preserved at baseline in the LV of MCT-4. MCT-6 animals, however, presented low peak LV systolic pressure and disturbed indexes of both LV contractility (Fig. 2) , such as reduced peak isovolumetric pressures and dP/dt max , and LV relaxation (Fig. 3) , such as reduced dP/dt min and prolonged time constant s. Despite these hemodynamic disturbances neither the EDLVP nor the EDLVD were changed (Fig. 3) .
Response of diastolic function to afterload elevations Both MCT-4 and MCT-6 revealed an impaired response of diastolic function to afterload elevations (Fig. 4) . This figure displays changes in the time constant s (panel A) and shifts of the EDPDR (panel B) with increasing afterloads. Effects on s are expressed by the ratio of test to baseline beats values. Time constant s was differently affected by afterload in control and in MCT-treated rats. Control animals responded to afterload elevations with shortening of s (acceleration of pressure fall) for almost the entire range of systolic LV pressures, apart from isovolumetric beats that showed a non-significant change in s. On the contrary, MCT-treated animals responded to afterload elevations with a prolongation of s (slowing of pressure fall). This slowing was observed only with the two highest afterload levels in MCT-4, while in MCT-6 such slowing was more pronounced and present over the entire range of systolic LV pressures. With regard to the EDPDR, in response to afterload elevations, it remained unaffected in control animals, but was upward shifted in both MCT-4 and MCT-6 groups. This upward shift was of similar magnitude in MCT-4 and MCT-6 (Fig. 4b) , but occurred at much lower systolic LV pressures in the later. Representative pressuredimension loops are presented (Fig. 5) .
Neurohumoral activation
The expression of genes involved in autocrine/paracrine systems was upregulated in the LV myocardium of MCTtreated rats compared with controls (Fig. 6) . Angiotensinconverting enzyme mRNA levels were progressively increased in MCT-4 and MCT-6, whereas endothelin-1 expression was only elevated in MCT-6.
Apoptosis
Apoptosis was significantly augmented in LV myocardium of both MCT-4 and MCT-6 groups, as compared with controls (Fig. 7a) . In the representative examples presented in Fig. 7b apoptotic cardiomyocytes can be easily identified in MCT groups.
Extracellular matrix composition
Regarding the extracellular matrix composition, we evaluated the gene expression of tenascin-C, an extracellular matrix glycoprotein as well as the LV interstitial collagen content. Both were significantly increased only in MCT-6 group (Fig. 8) .
LV myofilaments
With regard to myofilament composition, a significant elevation of the relative expression of myosin heavy-chain b-isoform was observed in both MCT-4 and MCT-6 LV myocardium compared with Ctrl-4 and Ctrl-6, respectively (Fig. 9) .
Discussion
The present study was undertaken to investigate the onset and progression of LV dysfunction in the course of PH and the underlying myocardial mechanisms, namely neurohumoral activation, extracellular matrix composition and apoptosis. A hemodynamic stress test with single-beat afterload elevations was used to detect early, load dependent, changes in LV diastolic function in animals with MCT induced PH. MCT-treated rats progressively developed PH, as evaluated by RVP max , selective RV myocardial hypertrophy, and increased EDRVP. As previously reported [33] , MCT-6 rats showed clinical signs of congestive heart failure, disturbed indexes of LV contractility and relaxation, and increased expression of ACE and ET-1 in the LV myocardium. A more detailed discussion on the possible causes of neuroendocrine activation in the non-overloaded LV is provided elsewhere [33] . MCT-6 animals also presented reductions in body weight and LVP max , previously interpreted as consequence of continuous severe sickness [36] , as well as, diminished heart rate, suggesting an attenuation of the sympathetic nervous system response [25, 33] . In contrast, MCT-4 rats showed no baseline LV hemodynamic changes. Nonetheless, single afterloaded test-beats revealed diastolic function impairment in MCT-4. Systolic performance, as assessed by the contractility indexes LVP iso and dP/dt max , was unchanged, but diastolic dysfunction was elicited in response to increased afterload (afterload-induced diastolic dysfunction; [29, 30] ). Diastole was evaluated with the time constant of isovolumetric relaxation s and the end-diastolic pressure-diameter relation (EDPDR), the former evaluates active relaxation while the latter is an in vivo estimate of myocardial stiffness. The dynamic process of myocardial relaxation goes on from the ejection phase to the early filling period. The main hemodynamic manifestation of myocardial relaxation, however, is LV pressure fall and its analysis, through the time constant s, allows a description of the course of myocardial relaxation [26] . Changes in afterload modify s and the rate of LV pressure fall. While in healthy hearts small afterload elevations accelerate LV pressure fall and only marked afterload increases slow it, in failing hearts even slight increases in afterload may induce slower relaxation. At a similar systolic LV pressure, in failing hearts the relative load, defined as the ratio of systolic LV pressure to isovolumetric LV pressure, is higher, the afterload reserve is surpassed and afterload mismatch yields a pronounced slowing of LV pressure fall, compared with healthy hearts [10, 31] .
Diastolic dysfunction is commonly defined, in hemodynamic terms, by an upward displacement of the EDPDR [26] , which reflects a decrease in diastolic distensibility [13] . Classically, it was held that only chronic conditions that altered the compliance and distensibility of the LV could change the filling conditions to the point of modifying the EDPDR. However, more recent work demonstrated that the EDPDR could be acutely shifted by load [25, 31] and neurohumoral stimulation [27, 28, 37] . Afterload mismatch induces incomplete myocardial relaxation that can be large enough to increase LV pressure at end-diastole and cause diastolic dysfunction. A slower course of myocardial relaxation and the decrease in time available for the ventricle to relax are the major underlying mechanisms of afterload-induced diastolic dysfunction [29, Fig. 4 Effects of acute left ventricular (LV) afterload elevations on LV diastolic function. a Fractional changes in time constant s (s test / s baseline ). b Upward shift in the end-diastolic pressure-dimension relation (EDPDR). Six beats with progressively higher peak systolic LV pressure (LVP max ) are represented: baseline, test-beats with a peak systolic LV pressure corresponding to 60, 70, 80, and 90% of the isovolumetric beat, and the isovolumetric test-beat (LVP iso ); n = 6 in each group. MCT-treated rats, distinctly from controls (*P = 0.002), presented a prolongation of the time constant s in test beats compared with baseline beat ( P \ 0.01), while controls presented an overall acceleration of relaxation and shortening of s, with the exception of the isovolumetric test beats. In MCT-6 the changes in s were more striking and observed for lower afterload levels than in MCT-4 (àP = 0.007). The upward shift of EDPDR in test-beats compared with baseline beat ( P \ 0.01) was more pronounced and observed for lower afterload levels in MCT-treated rats compared with controls (*P = 0.008) 30 ]. Compared with control rats, MCT-treated rats developed prolongation of time constant s and a larger upward shift of the EDPDR indicating that afterload mismatch occurred at lower relative loads. Curiously, although MCT-6, unlike MCT-4, presented prolongation of s at baseline that was aggravated with every step up in relative load, there were no differences between the two groups regarding the upward shift of the EDPDR induced by afterload. One possible reason is the difference in heart rates. Inappropriate increases in heart rate are known to upwardly displace the EDPDR even if relaxation rate is normal [49] . Conversely, the reduction in the heart rate of MCT-6 may have partly reverted afterload-dependent diastolic dysfunction by increasing the time available for relaxation and the extent of relaxation. Animals and patients with PH are known to respond badly to hemodynamic stress [19, 23, 45] . The present results suggest that increased systemic blood pressures may induce, or contribute to, hemodynamic deterioration in PH by leading to, or worsening of, LV diastolic dysfunction.
One of the most likely subcellular candidates for myocardial dysfunction is the altered myofilament composition. MCT-treated rats presented myosin heavy-chain isoform switch in the LV myocardium. The slower b-isoform was increased in the LV of both MCT-4 and MCT-6, as previously reported in different models of RV hypertrophy [17, 43, 46, 47] . Changes in the expression of enzymes involved in bioenergetics and cell metabolism such as pyruvate dehydrogenase kinase-4, acetyl-CoA dehydrogenase and mitochondrial ATP synthase [42, 43] as well as a reduced capillary proliferation [21] have also been described in the LV of PH rats. Contrastingly, calcium kinetics side, diastolic pressures are nicely matched at all afterload levels in the control animal, but become progressively higher as afterload increases, both in MCT-4 and MCT-6 animals. As Ctrl-4 and Ctrl-6 animals were entirely similar only a representative example of Ctrl-4 is given Fig. 6 Left ventricular (LV) mRNA levels of angiotensin-converting enzyme (ACE; a) and endothelin-1 (ET-1; b) in rats with monocrotaline (MTC)-induced pulmonary hypertension (MCT-4, n = 6; MCT-6, n = 6) and controls (Ctrl-4, n = 6; Ctrl-6, n = 6), 4 and 6 weeks after injection, respectively. Results are expressed as arbitrary units after normalization for GAPDH. The arbitrary unit was set as the average value of the Ctrl-4 group. ACE mRNA levels progressively increased in MCT-4 and MCT-6, whereas ET-1 mRNA levels were only increased 6 weeks after MCT injection P \ 0.05: * vs. Ctrl-4; vs. Ctrl-6; à vs. Basic Res Cardiol (2009) 104:535-545 541 regulator proteins such as the Ca 2? -ATPase of the sarcoendoplasmic reticulum and phospholamban were consistently reported to be unaltered in the non-overloaded LV [21, 42, 43] . To further explore the underlying mechanisms of LV myocardial dysfunction, we investigated neurohumoral activation, extracellular matrix composition and apoptosis.
Regarding local autocrine/paracrine related gene expression, MCT-4 rats showed increased ACE mRNA levels in the LV myocardium. However, only MCT-6 rats presented markedly increased expression of ET-1, and ACE was further upregulated compared with MCT-4. The activation of autocrine/paracrine systems, particularly for ET-1, was concomitant with the development of LV systolic and diastolic dysfunction in the baseline hemodynamic evaluation. It has been suggested that cardiac ET-1 may play a critical role in the functional deterioration of LV during the transition to congestive heart failure [18] . Indeed, chronic administration of ET-1, for 5 days, to engineered heart tissues, derived from cells of neonatal rat hearts, decreased the contractile response to calcium and isoprenaline and changed myosin heavy chain isoform and sarcoendoplasmic reticulum Ca 2? -ATPase expression in a signaling pathway that involved protein kinase-C and the Na ? /H ? exchanger [51] . Lower heart rate, LVP max and LV dysfunction under the stress of anesthesia and surgical manipulation could well be partly the consequence of refractoriness to adrenergic stimulation mentioned above. Further supporting the possibility that ET-1 might have an important role modulating LV function in PH we have previously demonstrated that chronic ET-1 blockade prevents functional deterioration of the LV Fig. 7 Left ventricular (LV) apoptosis is expressed as TUNEL-positive cell percentage (a). There is a significant increase in apoptosis in both MCT-4 and MCT-6 groups (P \ 0.05: * vs. Ctrl-4; vs. Ctrl-6). Representative examples from rats with monocrotaline-induced pulmonary hypertension (MCT) and controls (Ctrl) 4 and 6 weeks after injection are presented in b (arrows apoptotic cells) myocardium in PH rats, restoring normal contractile response to increasing frequencies of stimulation [33] .
A possible molecular mechanism involved in the left ventricular dysfunction that accompanied severe PH is altered extracellular matrix composition and fibrillar collagen content [6, 8, 38] . Tenascin-C is synthesized by fibroblasts, highly expressed in embryonic tissues, and upregulated by both mechanical stress [2] and neuroendocrine mediators [34] in adult tissues under pathological conditions such as myocardial infarction [16] . Additionally, several pro-inflammatory cytokines, growth factors and neurohumoral peptides that stimulate tenascin-C synthesis [8, 34, 42] also participate in myocardial dysfunction induced by MCT [6, 33] . Tenascin-C is an important regulator of extracellular matrix and induces several metalloproteinases which activation is implicated in cardiac remodeling [44] . In the present study, we could demonstrate that there is a significant increase in myocardial interstitial collagen content and tenascin-C gene expression only 6 weeks after MCT injection, suggesting that changes in extracellular matrix composition may partly underlie the late deterioration of LV function in MCT-induced PH. There are evidences suggesting that cell cycle and apoptosis pathways are co-activated in pressure-overload RV in MCT model [5] . In this sequence, we assessed the LV myocardial apoptosis, and found increased rates of apoptosis both in MCT-4 and MCT-6. Although there is some controversy about the role of apoptosis in chronic heart failure [1, 7, 22] , this results suggest that it might be another possible mechanism involved in early events of LV dysfunction.
In conclusion, selectively RV overloaded MCT-treated rats develop, on hemodynamic assessment, LV dysfunction that is accompanied by myosin heavy-chain isoform switch and local LV autocrine/paracrine system activation. Despite the changes in myocardial molecular phenotype, such as MHC isoform switch, increased apoptosis and ACE upregulation, in the LV, 4 weeks after MCT injection, diastolic dysfunction can only be detected in MCT-4 by increasing afterload. Two weeks later, however, the LV myocardium of MCT-6 overexpresses ET-1 has increased collagen content and augmented gene expression of tenascin-C and presents baseline systolic and diastolic dysfunction. The transition to LV dysfunction and congestive heart failure in PH is a complex process that involves the activation of several subcellular pathways. Afterload-dependent diastolic disturbances of the LV may herald, or contribute to, hemodynamic deterioration in PH.
